Lifestyle Modification: Evaluation of the Effects of Physical Activity and Low-Glycemic-Index Mediterranean Diet on Fibrosis Score
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is one the most prevalent causes of chronic liver disease worldwide. In the absence of an approved drug treatment, lifestyle modification is the first intervention strategy. This study aimed to estimate the main effect of two different physical activity (PA) programs, and a Low-Glycemic-Index Mediterranean Diet (LGIMD), or their combined effect on liver fibrosis parameters in subjects with NAFLD. Methods: Subjects with moderate or severe NAFLD grade of severity (n = 144) were randomly assigned to six intervention arms for three months: LGIMD, PA programs, and their combination. Data were collected at baseline, 45 days, and 90 days. Transient elastography was performed to assess the outcome. Results: at 90 days, a statistically significant reduction in kPa was found among subjects following LGMID (−2.85, 95% CI −5.24, −0.45) and those following an LGIMD plus PA1 (−2.37, 95% CI −4.39, −0.35) and LGIMD plus Pa2 (−2.21, 95% CI −4.10, −0.32). The contrast between time 2 and time 1 of the LGIMD plus PA2 treatment showed a statistically significant increase, and vice versa: the contrast between time 3 and time 2 of the same treatment showed a statistically significant reduction. The PA1 and PA2 arms also showed reduced kPa, although the results did not reach statistical significance. Conclusions: The intervention arms, LGIMD, LGIMD+PA1, and LGIMD+PA2, reduced the fibrosis score.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In total, seven studies reported data revealed that the MD significantly reduced BMI [56–60, 62, 64](WMD = − 0.70 kg/m2, 95% CI = − 1.03 to − 0.36, P < 0.001)”
From Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and WC [56–60, 62, 64] (WMD = − 1.56 cm, 95% CI = − 3.02 to − 0.09, P = 0.04) in comparison to standard care or control diet”
From Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the controlled attenuation parameter (CAP) score decreased in all groups compared to baseline, the changes were not significantly different between the groups.”
From Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In another study by Cruci et al. [58] evaluating the effects of a low-glycemic index MD (LGIMD), LGIMD with aerobic exercise, and LGIMD with combined aerobic-resistance exercise, no significant differences in BMI, WC, and AST were observed between the groups after 3 months.”
From Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Regarding liver fibrosis, four RCTs showed improvements in fibrosis outcomes with the MD compared to standard care [59, 61], Research Center for Food and Nutrition diet [58], and low-fat diet [55].”
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619 · cited 1×
“The International Physical Activity Questionnaire Long Form (IPAQ-LF) was used to collect information on PA [18] and information about alcohol intake and eating behavior was collected by using the European Prospective Investigation into Cancer and Nutrition Food Frequency Questionnaire (EPIC FFQ) [19].”
MethodLongitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550 · cited 6×
“GEE analysis results are shown in Table 3.”
MethodInfluentialChalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · cited 1×
“The NAFLD practice guidelines of the American Association for the Study of Liver Diseases (AASLD) advise that a body-weight loss of at least 3% to 5% decreases hepatic steatosis, and histologic improvements (including fibrosis) are seen with a greater body-weight reduction (7%) [35].”
MethodAge-predicted maximal heart rate revisited
Tanaka, H., Monahan, K. D., & Seals, D. R. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01054-8 · Cited by 3,775 · cited 1×
“The maximum age-predicted heart rate was determined by using Tanaka’s formula [29].”
MethodMechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541 · cited 8×
“It has been shown that AGEs are increased in NASH patients, and they are correlated positively with insulin resistance and negatively with adiponectin [41].”
BackgroundInfluentialVilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492 · cited 3×
“In obese subjects, an improvement of fibrosis has been shown with weight loss [8]; weight is considered an independent predictor for progression of steatosis to liver fibrosis in NAFLD [10].”
BackgroundRiboli, E., Hunt, K., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondière, U., Hémon, B., Casagrande, C., Vignat, J., et al. (2002) · Public Health Nutrition · doi:10.1079/phn2002394 · Cited by 1,866 · cited 1×
“The International Physical Activity Questionnaire Long Form (IPAQ-LF) was used to collect information on PA [18] and information about alcohol intake and eating behavior was collected by using the European Prospective Investigation into Cancer and Nutrition Food Frequency Questionnaire (EPIC FFQ) [19].”
MethodTreatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347 · cited 1×
“It has been shown that AGEs are increased in NASH patients, and they are correlated positively with insulin resistance and negatively with adiponectin [41].”
BackgroundCusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792 · cited 1×
“MD limits the consumption of processed [38] and high fructose foods [39] and limits the excessive intake of advanced glycation end products (AGEs) (a heterogeneous class of non-enzymatic products derived from protein, lipid, and nucleic acid glycation) [40].”
BackgroundFeldstein, A. E., Wieckowska, A., Lopez, R. A., Liu, Y.-C., Zein, N. N., & McCullough, A. J. (2009) · Hepatology · doi:10.1002/hep.23050 · Cited by 712 · cited 1×
“Other studies showed that CK-18, a marker of apoptosis, is related to liver damage and fibrosis [47]; PA promoted the reduction in CK-18 levels and other circulating cytokines in subjects with NAFLD, thus playing a protective role [48].”
BackgroundJohnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631 · cited 1×
“However, these results are supported by some studies which evidenced that PA alone in the management of NAFLD is not sufficient, as it produces only a minimal reduction in body weight [12,42], although it improves the liver dysfunction underlying NAFLD including fat accumulation, inflammation, and fibrosis [43].”
ResultVisceral fat: A key mediator of steatohepatitis in metabolic liver disease†
van der Poorten, D., Milner, K., Hui, J., Hodge, A., Trenell, M. I., Kench, J. G., London, R., Peduto, T., Chisholm, D. J., & George, J. (2008) · Hepatology · doi:10.1002/hep.22350 · Cited by 607 · cited 2×
“showed that an influx of fatty acids and synthesis of cytokines and adipokines promotes hepatic lipid accumulation, insulin resistance, and inflammation [46].”
BackgroundHallsworth, K., Fattakhova, G., Hollingsworth, K. G., Thoma, C., Moore, S., Taylor, R., Day, C. P., & Trenell, M. I. (2011) · Gut · doi:10.1136/gut.2011.242073 · Cited by 529 · cited 1×
“reported that resistance PA improves NAFLD regardless of body weight changes; 8 weeks of PA reduced intrahepatic triglyceride levels by 13% [50].”
BackgroundAerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review
Hashida, R., Kawaguchi, T., Bekki, M., Omoto, M., Matsuse, H., Nago, T., Takano, Y., Ueno, T., Koga, H., George, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.023 · Cited by 509 · cited 2×
“Resistance activity improves NAFLD by promoting hypertrophy of type II muscle fibers, alters myokine levels, and activates glucose transporter 4 [49].”
BackgroundKistler, K. D., Brunt, E. M., Clark, J. M., Diehl, A. M., Sallis, J. F., & Schwimmer, J. B. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.488 · Cited by 433 · cited 8×
“It has been shown that AGEs are increased in NASH patients, and they are correlated positively with insulin resistance and negatively with adiponectin [41].”
BackgroundInfluentialDietary Advanced Glycation End Products and Their Role in Health and Disease
Uribarri, J., del Castillo, M. D., de la Maza, M. P., Filip, R., Gugliucci, A., Luevano-Contreras, C., Macías-Cervantes, M. H., Markowicz Bastos, D. H., Medrano, A., Menini, T., et al. (2015) · Advances in Nutrition · doi:10.3945/an.115.008433 · Cited by 369 · cited 2×
“MD limits the consumption of processed [38] and high fructose foods [39] and limits the excessive intake of advanced glycation end products (AGEs) (a heterogeneous class of non-enzymatic products derived from protein, lipid, and nucleic acid glycation) [40].”
Backgroundvan Dijk, S. J., Feskens, E. J., Bos, M. B., Hoelen, D. W., Heijligenberg, R., Bromhaar, M. G., de Groot, L. C., de Vries, J. H., Müller, M., & Afman, L. A. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27792 · Cited by 291 · cited 1×
“Furthermore, the supply of antioxidants such as vitamins, selenium, and polyphenols contributes to a reduced production of proinflammatory mediators and ROS [37].”
BackgroundLe, M. H., Devaki, P., Ha, N. B., Jun, D. W., Te, H. S., Cheung, R. C., & Nguyen, M. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173499 · Cited by 287 · cited 1×
“The presence of fibrosis is the most relevant feature associated with liver-related outcomes such as mortality [5].”
BackgroundTargher, G. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02025.x · Cited by 242 · cited 1×
“It is considered a phenotype of a metabolic syndrome that occurs in the liver [2].”
BackgroundHoughton, D., Thoma, C., Hallsworth, K., Cassidy, S., Hardy, T., Burt, A. D., Tiniakos, D., Hollingsworth, K. G., Taylor, R., Day, C. P., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.07.031 · Cited by 209
Advanced glycation endproducts: from precursors to RAGE: round and round we go
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2012) · Amino Acids · doi:10.1007/s00726-010-0773-2 · Cited by 159 · cited 1×
“MD limits the consumption of processed [38] and high fructose foods [39] and limits the excessive intake of advanced glycation end products (AGEs) (a heterogeneous class of non-enzymatic products derived from protein, lipid, and nucleic acid glycation) [40].”
BackgroundMediterranean Adequacy Index of Italian diets
Alberti-Fidanza, A., & Fidanza, F. (2004) · Public Health Nutrition · doi:10.1079/phn2004557 · Cited by 153 · cited 1×
“To assess adherence to the LGIMD and the CD diets, the Mediterranean Adequacy Index (MAI) was chosen as the relevant measure [25].”
MethodDefinition of the Mediterranean Diet Based on Bioactive Compounds
Saura-Calixto, F., & Goñi, I. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390701764732 · Cited by 150 · cited 1×
“The high fiber content of MD has been shown to protect against becoming overweight or obese by reducing feelings of hunger, as well as through calorie density due to its low glycemic index [36].”
BackgroundOh, S., So, R., Shida, T., Matsuo, T., Kim, B., Akiyama, K., Isobe, T., Okamoto, Y., Tanaka, K., & Shoda, J. (2017) · Scientific Reports · doi:10.1038/srep43029 · Cited by 146 · cited 1×
“However, these results are supported by some studies which evidenced that PA alone in the management of NAFLD is not sufficient, as it produces only a minimal reduction in body weight [12,42], although it improves the liver dysfunction underlying NAFLD including fat accumulation, inflammation, and fibrosis [43].”
ResultMisciagna, G., del Pilar Díaz, M., Caramia, D. V., Bonfiglio, C., Franco, I., Noviello, M. R., Chiloiro, M., Abbrescia, D. I., Mirizzi, A., Tanzi, M., et al. (2017) · The Journal of nutrition, health and aging · doi:10.1007/s12603-016-0809-8 · Cited by 134 · cited 2×
“Two different diets were assigned: CD based on the CREA-AN guidelines [24] and LGIMD [14].”
BackgroundMethodSelf-citationHoeger, W. W. K., & Hopkins, D. R. (1992) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.1992.10607580 · Cited by 132
Kim, D., Konyn, P., Cholankeril, G., & Ahmed, A. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.06.029 · Cited by 130
Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease
Fealy, C. E., Haus, J. M., Solomon, T. P. J., Pagadala, M., Flask, C. A., McCullough, A. J., & Kirwan, J. P. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00127.2012 · Cited by 102 · cited 1×
“Other studies showed that CK-18, a marker of apoptosis, is related to liver damage and fibrosis [47]; PA promoted the reduction in CK-18 levels and other circulating cytokines in subjects with NAFLD, thus playing a protective role [48].”
BackgroundValidity of a two kilometre walking test for estimating maximal aerobic power in overweight adults.
Laukkanen, R. M. T., Oja, P., Pasanen, M. E., & VUORI, I. M. (1992) · PubMed · Cited by 96
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
Campos-Murguía, A., Ruiz‐Margáin, A., González-Regueiro, J. A., & Macías‐Rodríguez, R. U. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i39.5919 · Cited by 85 · cited 2×
“Lifestyle modifications, mainly diet and PA, are the first line of intervention for NAFLD/NASH as the pharmacological management is very poor [7].”
BackgroundKim, Y., Chang, Y., Cho, Y. K., Ahn, J., Shin, H., & Ryu, S. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.006 · Cited by 79 · cited 1×
“In obese subjects, an improvement of fibrosis has been shown with weight loss [8]; weight is considered an independent predictor for progression of steatosis to liver fibrosis in NAFLD [10].”
BackgroundThe Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH
Loomba, R. S., & Chalasani, N. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.016 · Cited by 77
Franco, I., Bianco, A., Mirizzi, A., Campanella, A., Bonfiglio, C., Sorino, P., Notarnicola, M., Tutino, V., Cozzolongo, R., Giannuzzi, V., et al. (2020) · Nutrients · doi:10.3390/nu13010066 · Cited by 68 · cited 3×
“Details about the primary study have already been published elsewhere [16].”
BackgroundSelf-citationCharatcharoenwitthaya, P., Kuljiratitikal, K., Aksornchanya, O., Chaiyasoot, K., Bandidniyamanon, W., & Charatcharoenwitthaya, N. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000316 · Cited by 64
Exercise training attenuates adipose tissue fibrosis in diet-induced obese mice
Kawanishi, N., Niihara, H., Mizokami, T., Yano, H., & Suzuki, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.004 · Cited by 53 · cited 1×
“Being overweight or obese promotes the development of NAFLD, a progressive liver disease that could include simple steatosis, NASH, fibrosis, and cirrhosis without excessive alcohol consumption (<20 g day−1) [31].”
BackgroundEguchi, Y., Wong, G., Lee, E. J., Akhtar, O., Lopes, R., & Sumida, Y. (2020) · JGH Open · doi:10.1002/jgh3.12349 · Cited by 44 · cited 1×
“Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver disease, affecting about one third of the world’s population [1].”
BackgroundOh, S., Tanaka, K., Tsujimoto, T., So, R., Shida, T., & Shoda, J. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0143 · Cited by 43 · cited 3×
“Overall, a valid approach indicates that the beneficial effects of PA on NAFLD and associated conditions are greater when exercise is combined with a dietary regimen [42,51].”
BackgroundResultMangla, N., Ajmera, V. H., Caussy, C., Sirlin, C., Brouha, S., Bajwa-Dulai, S., Madamba, E., Bettencourt, R., Richards, L., & Loomba, R. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.05.003 · Cited by 38
How Does High-Fat Diet Induce Adipose Tissue Fibrosis?
Pessin, J. E., & Kwon, H. (2012) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318271fdb9 · Cited by 36 · cited 1×
“Recently, fibrosis of adipose tissue has been shown to occur in obesity, along with inflammation [32] and these facts have been shown to be causally linked to the pathogenesis of several chronic inflammatory diseases, such as atherosclerosis and NASH [33].”
BackgroundTutino, V., Nunzio, V. D., Caruso, M. G., Bonfiglio, C., Franco, I., Mirizzi, A., Leonardis, G. D., Cozzolongo, R., Giannuzzi, V., Giannelli, G., et al. (2018) · Nutrients · doi:10.3390/nu10091299 · Cited by 36
Self-citationButtacavoli, M., Gruttad’Auria, C. I., Olivo, M., Virdone, R., Castrogiovanni, A., Mazzuca, E., Marotta, A. M., Marrone, O., Madonia, S., & Bonsignore, M. R. (2015) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2015.08.009 · Cited by 29
Lee, S. J., & Kim, S. U. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1608820 · Cited by 26 · cited 1×
“Following the literature, cut-off points were set at <248, 248–267, 268–279, and ≥280 dB/m for absent, mild, moderate, or severe NAFLD, respectively [21].”
BackgroundMiryan, M., Darbandi, M., Moradi, M., Najafi, F., Soleimani, D., & Pasdar, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1062008 · Cited by 24 · cited 3×
“MD helps to improve metabolic health and weight control thanks to an increased intake of whole grains, fruits, vegetables, legumes, nuts, and fish and a reduced intake of red and processed meats and dairy products [9].”
BackgroundInfluentialFranco, I., Bianco, A., Díaz, M. D. P., Bonfiglio, C., Chiloiro, M., Pou, S. A., Coquet, J. B., Mirizzi, A., Nitti, A., Campanella, A., et al. (2019) · Revista de la Facultad de Ciencias Médicas de Córdoba · doi:10.31053/1853.0605.v76.n1.21638 · Cited by 20 · cited 1×
“We have studied several aspects of these changes including the effects of an LGIMD alone [14], aerobic versus resistance PA [15], and the combination of diet and PA [16].”
BackgroundSelf-citationNon-Invasive Assessment of Non-Alcoholic Fatty Liver Disease: Ultrasound and Transient Elastography
Berzigotti, A. (2015) · Reviews on Recent Clinical Trials · doi:10.2174/1574887109666141216101630 · Cited by 19 · cited 1×
“All quality requirements for Fibroscan® measurements were complied with [23].”
BackgroundYabe, Y., Kim, T., Oh, S., Shida, T., Oshida, N., Hasegawa, N., Okada, K., Someya, N., Mizokami, Y., & Shoda, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18178918 · Cited by 9 · cited 4×
“NAFLD encloses a broad spectrum of diseases including non-alcoholic fatty liver (NAFL) as well as non-alcoholic steatohepatitis (NASH), in which inflammation and fibrosis develop [3].”
BackgroundInfluentialBianco, A., Franco, I., Curci, R., Bonfiglio, C., Campanella, A., Mirizzi, A., Fucilli, F., Giovanni, G. D., Giampaolo, N., Pesole, P. L., et al. (2023) · Nutrients · doi:10.3390/nu15102252 · Cited by 8 · cited 1×
“In addition, we highlighted the effect of combined PA and LGIMD on glucose metabolism parameters at different grades of NAFLD severity [17].”
BackgroundSelf-citationLiver, Muscle, and Insulin Resistance in Obese Subjects: Exercise Effects
Shoda, J., Oh, S., Shida, T., & Tanaka, K. (2015) · 体力科學 · doi:10.7600/jspfsm.64.217 · Cited by 2 · cited 1×
“reported that using PA as therapy slowed the progression of fibrosis in NAFLD patients by improving glucose metabolism, reducing oxidative stress, and keeping skeletal muscle mass functioning [44].”
Method
Cited by
Low-Grade Chronic Inflammation: a Shared Mechanism for Chronic Diseases
Cifuentes, M., Verdejo, H., Castro, P., Corvalán, A. H., Ferreccio, C., Quest, A. F. G., Kogan, M. J., & Lavandero, S. (2024) · Physiology · doi:10.1152/physiol.00021.2024 · Cited by 199
Arita, V. A., Cabezas, M. C., Hernández Vargas, J. A., Trujillo-Cáceres, S. J., Mendez Pernicone, N., Bridge, L. A., Raeisi-Dehkordi, H., Dietvorst, C. A. W., Dekker, R., Uriza-Pinzón, J. P., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04320-7 · Cited by 43
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay
Cernea, S. (2024) · Life · doi:10.3390/life14020272 · Cited by 36
“…or severe NAFLD demonstrated that a low-glycemic-index Mediterranean diet alone or combined with a physical activity program (aerobic with/without resistance exercises) was associated with significant reduction in liver fibrosis (estimated by vibration-controlled elastography) after 90 days [105].”
BackgroundStern, U. M., Wagenpfeil, G., Weber, S. N., Alqahtani, S. A., Michel, M. S., & Schattenberg, J. M. (2026) · European Journal of Nutrition · doi:10.1007/s00394-025-03870-z · Cited by 13
Tan, X., Zou, H., Guo, M., Liu, J., Huang, X., Yu, R., Liu, X., & Qin, C. (2026) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2026.101125 · Cited by 8
Metadata
- Authors
- Curci, R., Bianco, A., Franco, I., Bonfiglio, C., Campanella, A., Mirizzi, A., Giannuzzi, V., Cozzolongo, R., Veronese, N., & Osella, A. R.
- Affiliations
- Gastroenterology Hospital "Saverio de Bellis" (IT)
- Mécanismes physiopathologiques et conséquences des calcifications cardiovasculaires (FR)
- University of Palermo (IT)
- Corresponding author
- Osella, Alberto Ruben
- ORCID
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-08-10
- Volume
- 15
- Issue
- 16
- Pages
- 3520
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10459797
- OpenAlex
- W4385737869
- Cited by
- 11
- References
- 49
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 2
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS UniPA (University of Palermo) (submittedVersion, other-oa)
- Funders
- RC 2012–2014 (D.D.n.110/2014)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- non-alcoholic fatty liver disease, liver fibrosis, physical activity, lifestyle modification, transient elastography, combined diet and exercise intervention
- MeSH terms
- Humans, Life Style, Liver Cirrhosis, Exercise, Diet, Mediterranean, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

